Vancomycin area under the curve/minimum inhibitory concentration and trough level concordance–evaluation on an urban health unit

BACKGROUND: A vancomycin AUC/MIC (area under the curve/minimum inhibitory concentration) of 400–600 mg•h/L is associated with improved clinical outcomes for the treatment of methicillin resistant Staphylococcus aureus (MRSA) infections. Currently, there are still limited studies evaluating the relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Maggie, Lee, Colin, Gnyra, Michelle, Wong, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716452/
https://www.ncbi.nlm.nih.gov/pubmed/36465428
http://dx.doi.org/10.1177/20499361221140368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716452/
https://www.ncbi.nlm.nih.gov/pubmed/36465428
http://dx.doi.org/10.1177/20499361221140368

Ejemplares similares